David C Chang1, Ralitza P Parina2, Samuel E Wilson3. 1. Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston. 2. School of Medicine, University of California-San Diego. 3. Department of Surgery, University of California-Irvine, Orange.
Abstract
IMPORTANCE: To our knowledge, long-term outcomes of open and endovascular (EVAR) repairs of abdominal aortic aneurysms (AAAs) have not been studied on a population level outside a controlled trial setting. OBJECTIVE: To determine long-term outcomes of EVAR vs open repair on a population level. DESIGN, SETTING, AND PARTICIPANTS: Analysis of the longitudinally linked California Office of Statewide Health Planning and Development inpatient database from 2001 to 2009. Median follow-up was 3.3 years. EXPOSURES: Endovascular vs open repairs. MAIN OUTCOMES AND MEASURES: Mortality and complications at 30 days, as well as long-term mortality and complications up to 9 years. RESULTS: In this observational study, a total of 23 670 patients were studied, with 52% receiving EVAR. Endovascular repair was associated with improved 30-day outcomes (all-cause mortality, readmission, surgical site infection, pneumonia, and sepsis), as well as significantly improved survival until 3 years postoperatively. After 3 years, mortality was higher for patients who underwent an EVAR repair. No significant difference in long-term mortality was observed for the entire cohort on adjusted analysis (hazard ratio, 0.99; 95% CI, 0.94-1.04; P = .64). Endovascular repair was found to be associated with a significantly higher rate of reinterventions and AAA late ruptures. CONCLUSIONS AND RELEVANCE: The survival advantage for EVAR repair in a statewide population is maintained for 3 years. After 3 years, EVAR repair was associated with higher mortality; however, these mortality differences did not reach statistical significance over the entire study period. Reintervention and late AAA rupture rates are higher after EVAR repair.
IMPORTANCE: To our knowledge, long-term outcomes of open and endovascular (EVAR) repairs of abdominal aortic aneurysms (AAAs) have not been studied on a population level outside a controlled trial setting. OBJECTIVE: To determine long-term outcomes of EVAR vs open repair on a population level. DESIGN, SETTING, AND PARTICIPANTS: Analysis of the longitudinally linked California Office of Statewide Health Planning and Development inpatient database from 2001 to 2009. Median follow-up was 3.3 years. EXPOSURES: Endovascular vs open repairs. MAIN OUTCOMES AND MEASURES: Mortality and complications at 30 days, as well as long-term mortality and complications up to 9 years. RESULTS: In this observational study, a total of 23 670 patients were studied, with 52% receiving EVAR. Endovascular repair was associated with improved 30-day outcomes (all-cause mortality, readmission, surgical site infection, pneumonia, and sepsis), as well as significantly improved survival until 3 years postoperatively. After 3 years, mortality was higher for patients who underwent an EVAR repair. No significant difference in long-term mortality was observed for the entire cohort on adjusted analysis (hazard ratio, 0.99; 95% CI, 0.94-1.04; P = .64). Endovascular repair was found to be associated with a significantly higher rate of reinterventions and AAA late ruptures. CONCLUSIONS AND RELEVANCE: The survival advantage for EVAR repair in a statewide population is maintained for 3 years. After 3 years, EVAR repair was associated with higher mortality; however, these mortality differences did not reach statistical significance over the entire study period. Reintervention and late AAA rupture rates are higher after EVAR repair.
Authors: Muzammil H Syed; Mohamad A Hussain; Zeyad Khoshhal; Konrad Salata; Beidaa Altuwaijri; Bertha Hughes; Norah Alsaif; Charles de Mestral; Subodh Verma; Mohammed Al-Omran Journal: Can J Surg Date: 2018-08 Impact factor: 2.089
Authors: Muzammil H Syed; Mohamad A Hussain; Zeyad Khoshhal; Konrad Salata; Beidaa Altuwaijri; Bertha Hughes; Norah Alsaif; Charles de Mestral; Subodh Verma; Mohammed Al-Omran Journal: Can J Surg Date: 2018-06-01 Impact factor: 2.089
Authors: Carlo Setacci; Pasqualino Sirignano; Vittorio Fineschi; Paola Frati; Giovanna Ricci; Francesco Speziale Journal: Ann Med Surg (Lond) Date: 2017-02-20
Authors: Konrad Salata; Mohamad A Hussain; Charles de Mestral; Elisa Greco; Badr A Aljabri; Muhammad Mamdani; Thomas L Forbes; Deepak L Bhatt; Subodh Verma; Mohammed Al-Omran Journal: JAMA Netw Open Date: 2019-07-03
Authors: Martin H Bernardi; Dominik G Haider; Christoph M Domenig; Robin Ristl; Michael Hagmann; Markus Haisjackl; Michael J Hiesmayr; Andrea Lassnigg Journal: Medicine (Baltimore) Date: 2019-07 Impact factor: 1.817
Authors: Piotr Kulig; Krzysztof Lewandowski; Bartłomiej Banaś; Piotr Piekorz; Andrzej Kostka; Maciej Zaniewski Journal: Wideochir Inne Tech Maloinwazyjne Date: 2018-02-07 Impact factor: 1.195
Authors: Bartosz Symonides; Andrzej Śliwczyński; Zbigniew Gałązka; Jarosław Pinkas; Zbigniew Gaciong Journal: PLoS One Date: 2018-06-14 Impact factor: 3.240